Biomedica Immunoassays started its own R&D programme in 1988 and now produces a range of innovative immunoassays for clinical research in the field of cardiorenal diseases as well as mineral and bone disorders.
We are setting the standard for clinical research using serum-based calibrators and controls, thus enabling researchers to collect biologically reliable data. The supplied immunoassays are fully validated. A worldwide distribution network has been established for these lines: cardiology, osteology, nephrology, and oncology. The company’s manufacturing processes comply with ISO 9001:2015 management system standards and conform to GMP/GLP guidelines. Biomedica’s experienced and qualified team of professionals provides technical and scientific support.